STOCK TITAN

Cronos Group Inc. - $CRON STOCK NEWS

Welcome to our dedicated page for Cronos Group news (Ticker: $CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cronos Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cronos Group's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
-
Rhea-AI Summary
Cronos Group Inc. confirms receiving unsolicited indications of interest from third parties for potential transactions. The company is reviewing these indications but no assurance of agreement or transaction. No further announcements unless required by law.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.13%
Tags
conferences
-
Rhea-AI Summary
Cronos Group Inc., an innovative global cannabinoid company, announced that Mike Gorenstein, Chairman, President and CEO, will speak at the Canaccord Genuity 7th Annual Global Cannabis Conference on May 18, 2023. A live webcast will be available on the Company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.53%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.7%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
Cronos Group Inc.

Nasdaq:CRON

CRON Rankings

CRON Stock Data

1.02B
203.49M
46.57%
13.1%
1.46%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
TORONTO

About CRON

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.